New technology detects breast cancer relapses up to five years in advance

Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has developed a tool to monitor treatment response in patients with solid tumors from a simple blood sample. This advance could represent a turning point in post-treatment follow-up.
š Full Story

My guide to picking stocks during market volatility
- 'Deranged': GOP Rep. Files Police Report Over Troubling Alleged Incident Involving Pro-Hamas Agitator
- A timeline of the US semiconductor market in 2025 - Rebecca Szkutak
- This Common HSA Mistake Could Cost You Thousands of Dollars
- IDF General: War Will Not End Until Missile, Nuclear Threat Destroyed - Diana Zapata
- Do You Need to Eat Protein Within 30 Minutes of Waking Up? What Experts Say - Christina Manian, RDN
- VeriSilicon Launches Advanced VC9800 Series for Next-Gen Data Centers - Sean George

The Wolf-Krugman Exchange: The cost of losing trust in the US | FT Podcasts
- 6 Major Mistakes Dermatologists Wish You'd Stop Making With Spray Sunscreen - Stephanie Anderson Witmer
- Check Your Vitamins: Gummy Supplements Sold at Aldi, BJās, and More Recalled Nationwide - Amber Brenza
- N. Korea discharges uranium waste into waters flowing to S. Korea - Diana Zapata
- Moscow claims capturing another village in Sumy, Putin seeks ābuffer zoneā - Diana Zapata
- āINSIDEā Review (TRIBECA) | A Haunting, Opera-Like Prison Drama Anchored By Three Glorious Performances - Aayush Sharma
- Watch the Kulhad Pizza Couple New Viral Video - Aaradhana Chaurasia